Everest Medicines Limited (HKG:1952)
Hong Kong · Delayed Price · Currency is HKD 48.98
+0.52 (1.07%)
Oct 31, 2025, 4:08 PM HKT
Everest Medicines Market Cap
Everest Medicines has a market cap or net worth of 17.3 billion as of October 31, 2025. Its market cap has increased by 113.90% in one year.
Market Cap
17.30B
Enterprise Value
16.37B
Revenue
932.82M
Ranking
n/a
PE Ratio
n/a
Stock Price
48.98
Market Cap Chart
Since October 9, 2020, Everest Medicines's market cap has decreased from 20.64B to 17.30B, a decrease of -16.17%. That is a compound annual growth rate of -3.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 17.30B | 10.97% |
| Dec 31, 2024 | 15.59B | 132.87% |
| Dec 29, 2023 | 6.70B | 24.60% |
| Dec 30, 2022 | 5.37B | -47.96% |
| Dec 31, 2021 | 10.33B | -47.98% |
| Dec 31, 2020 | 19.85B | -3.81% |
| Oct 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 269.34B |
| Hansoh Pharmaceutical Group Company | 209.22B |
| JD Health International | 194.33B |
| WuXi Biologics | 148.69B |
| Innovent Biologics | 138.28B |
| Sino Biopharmaceutical | 122.81B |
| Akeso | 102.15B |
| Sichuan Kelun-Biotech Biopharmaceutical | 98.31B |